RxDoctor Payments DataLook up a doctor →

Hari Bezwada, MD

Orthopaedic Surgery · Princeton, NJNPI 1861426835

Payments from drug & device makers

$346,257in general payments, 2019–2025

Across 382 payments — averaging $906.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$135K
  • Corentec America Inc$107K
  • Pacira Therapeutics, Inc.$51K
  • Maxx Orthopedics, Inc.$40K
  • Ferring Pharmaceuticals Inc.$10K
  • Smith+Nephew$376
  • plus $2K from 17 others
$58,200in research payments, 2019–2025

Across 4 payments — averaging $14,550 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Maxx Orthopedics, Inc.$58K

What the payments were for

  • Consulting fees$218,26963%
  • Speaking & faculty fees$47,70014%
  • Travel & lodging$28,4658%
  • Food & beverage$51,82315%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$346,257 in reported general payments places this provider in the 95th percentile of 587 orthopaedic surgery providers in New Jersey.

See all orthopaedic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$935,654
Medicare patients
832
Services billed
20,218

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl18$79
Tramadol Hcl15$63
Amoxicillin16$36
Meloxicam12$16

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Princeton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →